Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial - Ferolla, P; Brizzi, M P; Meyer, T (Lancet Oncol, 2017)
et al.